Medications

US approves Regeneron antibody treatment given to Trump

A COVID-19 antibody therapy used to treat President Donald Trump was approved by the US drug regulator on Saturday for people who aren't yet hospitalized by the disease but are at high risk.

Immunology

Study finds unique form of chronic sinusitis in older patients

Older patients with a diagnosis of chronic sinusitis—a disease of the nasal cavity and paranasal sinuses that often persists over many years—have a unique inflammatory signature that may render them less responsive to ...

Diseases, Conditions, Syndromes

Study identifies how Epstein-Barr virus triggers multiple sclerosis

Scientists have long suspected—but failed to prove—a link between certain viral infections and the development of multiple sclerosis, a crippling autoimmune disease that affects nearly 1 million Americans. Now, a study ...

page 2 from 40